Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Design and Innovation’s Michael Goldberg examined dearth of venture-capital funding in Ohio
- Materials Science and Engineering’s James McGuffin-Cawley discussed 3D printing availability for students
- Technology Services’ Sue Workman to discuss computer security
- Professor to present on AIDS vaccine potential at next Public Affairs Discussion group
- Common spice could help extend lives of mesothelioma patients